Investors Home  >  Investor Relations
Briefcase Printed Materials Email Alerts Download Center snapshot RSS

Investor Relations

Ticker: CNAT
4.49 (- 0.25)
Stock price graph

We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Conatus Pharmaceuticals's financial performance into perspective.

View all »   RSSRecent Releases

Jul 29, 2015
Conatus Pharmaceuticals to Report Second Quarter 2015 Financial Results

Jun 25, 2015
Conatus Announces Initial Baseline Data From Phase 2b POLT-HCV-SVR Clinical Trial of Emricasan Confirming Activity of Relevant Mechanisms and Opportunity for Histological Improvement

View all »Events & Presentations

Aug 5, 2015
Conatus Pharmaceuticals Second Quarter 2015 Financial Results
Webcast Listen to webcast

Jun 24, 2015
2nd Annual ROTH Healthcare Day